Bone marrow deficient in IFN-γ signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect

被引:23
作者
Capitini, Christian M. [1 ]
Herby, Sarah [1 ]
Milliron, Matthew [1 ]
Anver, Miriam R. [2 ]
Mackall, Crystal L. [1 ]
Fry, Terry J. [1 ,3 ]
机构
[1] NCI, Immunol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[2] NCI, Pathol Histotechnol Lab, Sci Applicat Int Corp SAIC Frederick, NIH, Frederick, MD 21701 USA
[3] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA
关键词
VERSUS-HOST-DISEASE; INTERFERON-GAMMA; T-CELLS; IMMUNE RECONSTITUTION; STEM-CELLS; NK CELLS; GRAFT; TRANSPLANTATION; IMMUNOTHERAPY; VACCINES;
D O I
10.1182/blood-2008-11-187385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vaccine-based expansion of T cells is one approach to enhance the graft-versus-tumor effect of allogeneic bone marrow transplantation (BMT), but the complex immunobiology of the allogeneic environment on responses to tumor vaccines has not been well characterized. We hypothesized that subclinical graft-versus-host disease (GVHD) impairs immunity, but modulation of gamma interferon (IFN-gamma) signaling could reverse this effect. Dendritic cell vaccines and donor lymphocyte infusions (DLIs) were incorporated into a minor histocompatibility antigen-mismatched, T cell-depleted, allogeneic BMT mouse model. Animals were then challenged with H-Y expressing tumors. CD4(+) and CD8(+) responses to H-Y were diminished in vaccinated allogeneic versus syngeneic BMT recipients with DLI doses below the threshold for clinical GVHD, especially in thymectomized hosts. IFN-gamma receptor 1-deficient (IFN-gamma R1(-/-)) T cells cannot cause GVHD but also have diminished vaccine responses. Remarkably, IFN-gamma R1(-/-) bone marrow abrogates GVHD, allowing higher DLI doses to be tolerated, but improves vaccine responses and tumor protection. We conclude that tumor vaccines administered after allogeneic BMT can augment graft-versus-tumor if GVHD is avoided and that prevention of IFN-gamma signaling on donor bone marrow is an effective approach to preventing GVHD while preserving immunocompetence. (Blood. 2009; 113: 5002-5009)
引用
收藏
页码:5002 / 5009
页数:8
相关论文
共 40 条
[1]  
Anderson LD, 2000, CANCER RES, V60, P5797
[2]   Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease [J].
Anderson, LD ;
Savary, CA ;
Mullen, CA .
BLOOD, 2000, 95 (07) :2426-2433
[3]   IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy [J].
Berner, Vanessa ;
Liu, Haiyan ;
Zhou, Qing ;
Alderson, Kory L. ;
Sun, Kai ;
Weiss, Jonathan M. ;
Back, Timothy C. ;
Longo, Dan L. ;
Blazar, Bruce R. ;
Wiltrout, Robert H. ;
Welniak, Lisbeth A. ;
Redelman, Doug ;
Murphy, William J. .
NATURE MEDICINE, 2007, 13 (03) :354-360
[4]  
Borrello I, 2000, BLOOD, V95, P3011
[5]   IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract [J].
Burman, Angela C. ;
Banovic, Tatjana ;
Kuns, Rachel D. ;
Clouston, Andrew D. ;
Stanley, Amanda C. ;
Morris, Edward S. ;
Rowe, Vanessa ;
Bofinger, Helen ;
Skoczylas, Renae ;
Raffelt, Neil ;
Fahy, Olivier ;
McColl, Shaun R. ;
Engwerda, Christian R. ;
McDonald, Kelli P. A. ;
Hill, Geoffrey R. .
BLOOD, 2007, 110 (03) :1064-1072
[6]   Immune reconstitution: From stem cells to lymphocytes [J].
Crooks, GM ;
Weinberg, K ;
Mackall, C .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) :42-46
[7]   Immunotherapy of established tumors using bone marrow transplantation with antigen gene-modified hematopoietic stem cells [J].
Cui, Y ;
Kelleher, E ;
Straley, E ;
Fuchs, E ;
Gorski, K ;
Levitsky, H ;
Borrello, I ;
Civin, CI ;
Schoenberger, SP ;
Cheng, LZ ;
Pardoll, DM ;
Whartenby, KA .
NATURE MEDICINE, 2003, 9 (07) :952-958
[8]   Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches [J].
Fry, Terry J. ;
Shand, Jessica L. ;
Milliron, Matthew ;
Tasian, Sarah K. ;
Mackall, Crystal L. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (08) :1257-1264
[9]   Interleukin-7 restores immunity in athymic T-cell-depleted hosts [J].
Fry, TJ ;
Christensen, BL ;
Komschlies, KL ;
Gress, RE ;
Mackall, CL .
BLOOD, 2001, 97 (06) :1525-1533
[10]   ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA [J].
GRATWOHL, A ;
HERMANS, J ;
APPERLEY, J ;
ARCESE, W ;
BACIGALUPO, A ;
BANDINI, G ;
DIBARTOLOMEO, P ;
BOOGAERTS, M ;
BOSI, A ;
CARRERAS, E ;
DEVERGIE, A ;
FERRANT, A ;
FIBBE, WE ;
FRASSONI, F ;
GAHRTON, G ;
GOLDMAN, J ;
IRIONDO, A ;
JACOBSEN, N ;
KOLB, HJ ;
LINK, H ;
MICHALLET, M ;
PRENTICE, HG ;
REIFFERS, J ;
VONRHEE, F ;
RUUTU, T ;
SCHWAIGHOFER, H ;
VERNANT, JP ;
DEWITTE, T ;
NIEDERWIESER, D .
BLOOD, 1995, 86 (02) :813-818